• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Fresenius Medical Care Ag ADR (NY: FMS )

    19.76 +0.22 (+1.13%)
    Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Fresenius Medical Care Ag ADR

    < Previous 1 2 3 Next >
    Current Analysis: Fresenius Medical Care (FMS)
    Fresenius Medical Care (FMS​​​​​​​) is the largest dialysis company in the world. Over the past year, Fresenius's share price fell just over 30% from $26.09 to $18.14 as of Monday’s market close. 
    Via Talk Markets
    Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    Fresenius Medical Care: Q4 Earnings Insights
    Via Benzinga
    A Preview Of Fresenius Medical Care's Earnings
    Via Benzinga
    Stock Analysis: Fresenius Medical Care
    Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. 
    Via Talk Markets
    Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway
    You can't go wrong by following in the Oracle's footsteps and buying these cheap Buffett stocks before the market catches on. 
    Via InvestorPlace
    Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
    Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and... 
    Via Benzinga
    Current Analysis: Fresenius Medical Care
    Fresenius Medical Care is the largest dialysis company in the world and a leading supplier of dialysis products, including machines, dialyzers, and concentrates. 
    Via Talk Markets
    Topics Supply Chain
    Exposures Supply Chain
    FMS Stock Earnings: Fresenius Medical Care Beats EPS, Beats Revenue for Q1 2024
    FMS stock results show that Fresenius Medical Care beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    AudioCodes Reports Downbeat Earnings, Joins Trupanion, Palantir Technologies And Other Big Stocks Moving Lower In Tuesday Pre-Market Session
    Via Benzinga
    Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Why Are Dialysis Provider Stocks Trading Higher On Tuesday?
    Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks 
    Via Benzinga
    Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. 
    Via Benzinga
    NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
    U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News
    Novo Nordisk tested its diabetes and weight-loss drug in patients with chronic kidney disease. 
    Via Investor's Business Daily
    Stock Market Whiplash
    We've also got a look at the international real estate market. 
    Via The Motley Fool
    Dialysis Player Fresenius Medical's Q4 Sales Hold Steady: Details
    Fresenius Medical Care Q4 2023 revenue: €4.9 billion. Patient volume growth is expected at 0.5%-2% in 2024. 
    Via Benzinga
    Fresenius Medical Care Hit By Major Data Breach: Half A Million Patients Potentially Affected
    Fresenius Medical Care (NYSE: FMS) said in a  
    Via Benzinga
    Only Have $100? 3 No-Brainer Stocks to Buy Right Now
    The stock market is such a well-oiled, wealth-generating machine that investors can start with just $100 to buy these no-brainer stocks. 
    Via InvestorPlace
    Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
    Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. 
    Via Investor's Business Daily
    Earnings Scheduled For February 20, 2024
    Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion. 
    Via Benzinga
    Stock Market Rallies, Hits Resistance; Novo Nordisk, JPMorgan, Exxon In Focus: Weekly Review
    The major indexes stalled at key levels amid weak breadth. 
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why Dialysis Stocks Plunged Today
    Novo Nordisk indicated one of its diabetes drugs could also be used to treat kidney disease. Here's what investors need to know. 
    Via The Motley Fool
    Why Shares of Fresenius Medical Care Were Dropping on Wednesday
    Positive trial news for a kidney failure drug could cut into business for dialysis therapies companies such as Fresenius. 
    Via The Motley Fool
    What's Going On With Kidney Dialysis Provider Stocks Today?
    DaVita Inc (NYSE: DVA), Fresenius Medical Care AG (NYSE: FMS), and Baxter International Inc (NYSE: BAX) shares fel 
    Via Benzinga
    Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in... 
    Via Benzinga
    Ozempic Is Moving a Bunch of Stocks Wednesday Morning
    Find out who the winners and losers are. 
    Via The Motley Fool
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.